BlackRock Institutional Trust’s Tandem Diabetes Care TNDM Stock Holding History

BlackRock Institutional Trust’s Portfolio TNDM Stock Details TNDM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$714K	Hold	33,190	–	–	﹤0.01%	3379
2016 Q3	$2.54M	Buy	33,190 +551	+2%	+$40.2K	﹤0.01%	2958
2016 Q2	$2.46M	Buy	32,639 +1,568	+5%	+$126K	﹤0.01%	2958
2016 Q1	$2.71M	Sell	31,071 -430	-1%	-$37.6K	﹤0.01%	2917
2015 Q4	$3.72M	Buy	31,501 +2,626	+9%	+$260K	﹤0.01%	2861
2015 Q3	$2.54M	Buy	28,875 +7,714	+36%	+$898K	﹤0.01%	3022
2015 Q2	$2.29M	Buy	21,161 +9,705	+85%	+$1.21M	﹤0.01%	3064
2015 Q1	$1.45M	Buy	11,456 +4,816	+73%	+$626K	﹤0.01%	3237
2014 Q4	$843K	Sell	6,640 -148	-2%	-$20.5K	﹤0.01%	3391
2014 Q3	$911K	Sell	6,788 -932	-12%	-$131K	﹤0.01%	3349
2014 Q2	$1.25M	Sell	7,720 -7,507	-49%	-$1.28M	﹤0.01%	3372
2014 Q1	$3.36M	Buy	15,227 +7,062	+86%	+$1.8M	﹤0.01%	2939
2013 Q4	$2.1M	Buy	+8,165	New	+$1.87M	﹤0.01%	3141

Other funds holding TNDM

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GIP

Granite Investment Partners El Segundo, California $1.63B AUM 38.09% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock Institutional Trust's TNDM Position: Q4 2016 in Review

BlackRock Institutional Trust held its Tandem Diabetes Care (TNDM) position steady in Q4 2016 at 33,190 shares worth $714K. The position accounts for ﹤0.01% of the portfolio, ranked #3379.

BlackRock Institutional Trust first reported a position in TNDM in Q4 2013 and has held it in 13 quarters since. The position peaked at $3.72M in Q4 2015. 75 funds tracked by Wall St. Rank hold TNDM as of Q4 2016.

BlackRock Institutional Trust held 33,190 shares of Tandem Diabetes Care worth $714K as of Q4 2016.
BlackRock Institutional Trust left its Tandem Diabetes Care share count unchanged in Q4 2016.
Tandem Diabetes Care made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #3379 holding.
BlackRock Institutional Trust first reported a position in Tandem Diabetes Care in Q4 2013 and has held it in 13 quarters since.
BlackRock Institutional Trust's Tandem Diabetes Care position peaked at $3.72M in Q4 2015.
75 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.